Search for: "Bausch "
Results 1 - 20
of 359
Sort by Relevance
|
Sort by Date
3 May 2024, 11:00 pm
“PROJECT WATSON” and “BAUSCH + LOMB” are printed on the label. [read post]
3 May 2024, 11:00 pm
“PROJECT WATSON” and “BAUSCH + LOMB” are printed on the label. [read post]
24 Apr 2024, 8:24 am
Co. of America, 844 N.Y.S.2d 257, 46 A.D.3d 224 (1st Dep't 2007), 9 Bausch & Lomb Inc. v. [read post]
8 Jan 2024, 2:15 pm
The FCA claim was brought by patent attorney Zachary Silbersher against Valeant Pharmaceuticals, predecessor to Canadian drugmaker Bausch Health. [read post]
8 Jan 2024, 2:15 pm
The FCA claim was brought by patent attorney Zachary Silbersher against Valeant Pharmaceuticals, predecessor to Canadian drugmaker Bausch Health. [read post]
6 Jan 2024, 1:24 am
’ In number 9, BREAKING: The EPO is able to listen, Thorsten Bausch of Hoffmann Eitle points out with irony a problem which has earned the EPO many top ranking articles on this blog over the last decade: its habit of ignoring criticism or input from staff members and representatives and users, about a wide range of issues. [read post]
4 Dec 2023, 7:15 am
” Top 3 Kluwer Patent Blog posts 1) EPO Propaganda Master Class – or: How to Justify Higher Fees for Lower Quality Work by Thorsten Bausch “It will be nothing new for regular readers of this blog that I and many others have long been advocating for more well-qualified examiners at the EPO. [read post]
4 Dec 2023, 7:14 am
” Top 3 Kluwer Patent Blog posts 1) EPO Propaganda Master Class – or: How to Justify Higher Fees for Lower Quality Work by Thorsten Bausch “It will be nothing new for regular readers of this blog that I and many others have long been advocating for more well-qualified examiners at the EPO. [read post]
5 Jan 2023, 3:30 am
Bausch & Lomb, (2d. [read post]
5 Dec 2022, 3:52 am
As Thorsten Bausch wrote on this blog earlier this week: ‘At present, we are far away from such a paradisiacal state; we are still in purgatory or even lower. [read post]
24 Nov 2022, 1:09 pm
’ Some observers of UPC developments, for instance Thorsten Bausch of Hoffmann Eitle who recently wrote this article, are concerned about the large proportion of ‘technical judges who are at the same time patent attorneys (and mostly partners) from IP law firms or from industry, i.e. from entities that inevitably have their own economic interests’. [read post]
29 Jul 2022, 11:15 am
This week in Other Barks & Bites: USPTO Director Vidal announces Federal Register notice on duty of disclosure requirements as Senate Judiciary advances a bill to create a USPTO-FDA interagency task force on drug patents; Senator Thom Tillis tells IAM that he will introduce patent eligibility legislation soon; the Federal Circuit affirms an attorneys’ fees award for forum shopping of patent infringement claims to avoid an adverse Section 101 ruling; both houses of Congress pass major… [read post]
29 Jul 2022, 11:15 am
This week in Other Barks & Bites: USPTO Director Vidal announces Federal Register notice on duty of disclosure requirements as Senate Judiciary advances a bill to create a USPTO-FDA interagency task force on drug patents; Senator Thom Tillis tells IAM that he will introduce patent eligibility legislation soon; the Federal Circuit affirms an attorneys’ fees award for forum shopping of patent infringement claims to avoid an adverse Section 101 ruling; both houses of Congress pass major… [read post]
5 Jul 2022, 1:16 pm
Bausch + Lomb’s successful return to the public markets in the second quarter proved to be an exception as the slowdown in IPO activity reached levels not seen in years. [read post]
24 Jun 2022, 9:08 pm
., 202 AD3d at 1253; see Matter of Bigdoski v Bausch & Lomb, 197 AD3d 1379, 1380 [2021]; Matter of Gandurski v Abatech Indus., Inc., 194 AD3d 1329, 1330 [2021]). [read post]
24 Jun 2022, 9:08 pm
., 202 AD3d at 1253; see Matter of Bigdoski v Bausch & Lomb, 197 AD3d 1379, 1380 [2021]; Matter of Gandurski v Abatech Indus., Inc., 194 AD3d 1329, 1330 [2021]). [read post]
16 Jun 2022, 9:15 am
A normal (statistically) patent filings week saw 29 new Patent Trial and Appeal Board (PTAB) proceedings (including a pair of post grant reviews) and 67 district court patent complaints, with another 76 terminations. [read post]
16 Jun 2022, 9:15 am
A normal (statistically) patent filings week saw 29 new Patent Trial and Appeal Board (PTAB) proceedings (including a pair of post grant reviews) and 67 district court patent complaints, with another 76 terminations. [read post]
6 Jun 2022, 9:17 am
Bausch & Lomb, Inc. [read post]
3 May 2022, 5:35 pm
OPDP cited Bausch for misleading risk presentations as well as misleading efficacy. [read post]
